4.8 Article

Activation of Mitofusin2 by Smad2-RIN1 Complex during Mitochondrial Fusion

Journal

MOLECULAR CELL
Volume 62, Issue 4, Pages 520-531

Publisher

CELL PRESS
DOI: 10.1016/j.molcel.2016.04.010

Keywords

-

Funding

  1. NIH [CA178443]
  2. Ohio State University College of Pharmacy, Davis Heart Lung Research Institute
  3. James Comprehensive Cancer Center
  4. Office Of The Director
  5. Office of Integrative Activities [1317771] Funding Source: National Science Foundation

Ask authors/readers for more resources

Smads are nuclear-shuttling transcriptional mediators of transforming growth factor-beta (TGF-beta) signaling. Although their essential nuclear roles in gene regulation during development and carcinogenesis are well established, whether they have important cytoplasmic functions remains unclear. Here we report that Smad2 is a critical determinant of mitochondrial dynamics. We identified mitofusin2 (MFN2) and Rab and Ras Interactor 1 (RIN1) as new Smad2 binding partners required for mitochondrial fusion. Unlike TGF-beta-induced Smad2/3 transcriptional responses underlying mitochondrial fragmentation and apoptosis, inactive cytoplasmic Smad2 rapidly promotes mitochondrial fusion by recruiting RIN1 into a complex with MFN2. We demonstrate that Smad2 is a key scaffold, allowing RIN1 to act as a GTP exchange factor for MFN2-GTPase activation to promote mitochondrial ATP synthesis and suppress superoxide production. These results reveal functional implications between Smads and mitochondrial dysfunction in cancer and metabolic and neurodegenerative disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available